Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment

Current Bladder Dysfunction Reports

Volumn 4, Issue 1, 2009, Pages 29-33

  MacDiarmid, Scott A ^a   Staskin, David R ^b  

^a Alliance Urology Specialists   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71249123735     PISSN: 19317212     EISSN: 19317220     Source Type: Journal    
DOI: 10.1007/s11884-009-0005-3     Document Type: Review

References (20)

1. Abrams P, Cardozo L, Fall M, et al.: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003, 61: 37-49.
2. Milsom I, Abrams P, Cardozo L, et al.: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87: 760-766. (Published erratum appears in BJU Int 2001, 88: 807.).
3. Milsom I, Irwin DE: A cross-sectional, population-based, multinational study of the prevalence of overactive bladder and lower urinary tract symptoms: results from the EPIC study. Eur Urol Suppl 2007, 6: 4-9.
4. Stewart WF, van Rooyen JB, Cundiff GW, et al.: Prevalence and burden of overactive bladder in the United States. World J Urol 1999, 44: 55-56.
5. Abrams P, Kelleher CJ, Kerr LA, Rogers RG: Overactive bladder significantly affects quality of life. Am J Manag Care 2000, 6: S580-S590.
6. Basra RK, Wagg A, Chapple C, et al.: A review of adherence to drug therapy in patients with overactive bladder. BJU Int 2008, 102: 774-779.
7. Wein AJ, Rackley RR: Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2006, 175: S5.
8. Alhasso AA, McKinlay J, Patrick K, Stewart L: Anticholinergic drugs versus non-drug active therapies for overactive bladder in adults. Cochrane Database Syst Rev 2006, 18: CD003103.
9. van der Pal F, Heesakkers JPFA, Bemelmans BLH: Current opinion on the working mechanism of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol 2006, 16: 261-267.
10. Cooperberg MR, Stoller ML: Percutaneous neuromodulation. Urol Clin North Am 2005, 32: 71-78.
11. Peters KM, MacDiarmid SA, Siegel SW, et al.: A randomized multicenter study comparing percutaneous tibial nerve stimulation with pharmaceutical therapy for the treatment of overactive bladder (OrBIT study) [abstract]. J Urol 2008, 179: 4.
12. Govier FE, Litwiller S, Nitti V, et al.: Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multi-center study. J Urol 2001, 165: 1193-1198.
13. van Balken MR, Vandoninck V, Gisolf KWH, et al.: Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 2001, 166: 914-918.
14. van der Pal F, van Balken MR, Heesakkers JPFA, et al.: Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation. BJU Int 2006, 97: 113-116.
15. van der Pal F, van Balken MR, Heesakkers JP, et al.: Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int 2006, 97: 113-116.
16. Klingler HC, Pycha A, Schmidbauer J, Marberger M: Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 2000, 56: 766-771.
17. Vandoninck V, van Balken MR, Finazzi-Agró E, et al.: Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn 2003, 22: 227-232.
18. Ruiz CB, Outeiriño PXM, Martinez PC, et al.: Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 2004, 45: 65-69.
19. Kim SW, Paick JS, Ku JH: Percutaneous posterior tibial nerve stimulation in patients with chronic pelvic pain: a preliminary study. Urol Int 2007, 78: 58-62.
20. MacDiarmid SA: Overactive bladder: improving the efficacy of anticholinergics by dose escalation. Curr Urol Rep 2003, 4: 446-451.